Salt Lake City-based Amedica has been granted marketing clearance for its Valeo interbody fusion device in Australia.
Here are four things to know:
1. The Valeo product line is made of Amedica's proprietary medical grade silicon nitride ceramic.
2. Ideal for fusion due to its nanostructured surface, osteoconductivity, osteoinductivity, anti-microbial properties and ease of radiographic imaging, Valeo's makeup is ideal for fusion.
3. Amedica develops and commercializes silicon nitride.
4. Amedica has published 45 papers in peer-reviewed journals, emphasizing the material's success in previous Australian-based trial runs.
Amedica CEO Sonny Bal said, "We look forward to working with Australian surgeons, and providing them with improved options for spinal fusion surgery."
More articles on devices:
Bioventus names David Varner VP of Marketing, Active Healing Therapies — 4 insights
Stryker opens 6k-square-foot endoscopy customer experience center — 4 notes